HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Tumour Immunology

Tumor immunology is a field of study focused on understanding the complex interactions between the immune system and cancer cells. However, tumors can develop mechanisms to evade immune detection and destruction. Research in tumor immunology explores various aspects, such as immune checkpoint pathways, tumor antigens, and the tumor microenvironment. Immune checkpoint inhibitors, a class of immunotherapy drugs, target specific proteins that inhibit immune responses, enabling the immune system to better recognize and attack cancer cells. Tumor immunology also investigates the role of immune cells, including T cells, B cells, and natural killer cells, in the antitumor immune response. Understanding the immune landscape of tumors helps develop personalized immunotherapies that harness the patient's immune system to target and destroy cancer cells. Advancements in tumor immunology have led to groundbreaking therapies like CAR-T cell therapy and personalized cancer vaccines. Ongoing research continues to unravel the complexities of tumor-immune interactions, with the goal of developing more effective and targeted immunotherapies for various types of cancer.

Submit your abstract Today

Watsapp